Author:
Knipper Sophie,Graefen Markus
Publisher
Springer Science and Business Media LLC
Reference25 articles.
1. Leitlinienprogramm Onkologie (Deutsche Krebsgesellschaft, Deutsche Krebshilfe, AWMF) (2016) Konsultationsfassung: Interdisziplinäre Leitlinie der Qualität S3 zur Früherken-nung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms, Lang-version 4.0.
http://leitlinienprogramm-onkologie.de/Prostatakarzinom.58.0.html
(AWMF Registernummer: 043/022OL)
2. D’Amico AV, Whittington R, Malkowicz SB, Schultz D, Blank K, Broderick GA et al (1998) Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 280(11):969–974
3. Sanda MG, Cadeddu JA, Kirkby E, Chen RC, Crispino T, Fontanarosa J, Freedland SJ, Greene K, Klotz LH, Makarov DV, Nelson JB, Rodrigues G, Sandler HM, Taplin ME, Treadwell JR (2017) Clinically Localized Prostate Cancer: AUA/ASTRO/SUO Guideline. Part I: Risk Stratification, Shared Decision Making, and Care Options. J Urol 199(3):683–690.
https://doi.org/10.1016/j.juro.2017.11.095
4. Dall’Era MA, Konety BR, Cowan JE, Shinohara K, Stauf F, Cooperberg MR et al (2008) Active surveillance for the management of prostate cancer in a contemporary cohort. Cancer 112(12):2664–2670
5. Hamdy FC, Donovan JL, Lane JA, Mason M, Metcalfe C, Holding P et al (2016) 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer. N Engl J Med 375(15):1415–1424
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献